17 October 2019

New biomedical innovations offer the promise of personalised medicine and health. Getting there requires huge amounts of sensitive personal health and care data.

The PhD thesis of Martin Boeckhout (Promotors prof. dr. A.L. Bredenoord and prof. dr. G.A. Zielhuis, defended on  June 6th, 2019) investigates the ethical challenges for health research infrastructures that facilitate the collection, management and use of such data.
 
Contemporary research data is usually collected with the expectation of systematic reuse. This is a positive development, but responsible data stewardship also requires quality control, privacy protection, and policies for sustained public availability of health research data. Ethics review is an important means to stimulate and provide oversight over such measures. For Dutch biobanks facilitating research with human tissue, this is now standard practice, but the shape of such review still varies considerably.

The systematic integration of data-driven research into health care could bring along additional risks to patients and patient care. However, research and care also stand to benefit from such integration, particularly for symptoms, diseases and treatments about which little is known. This calls for extensive involvement of patients and enhanced attention to the professional responsibility of health researchers. Expanding the scope of research settings calls for further reflection on the impact of research.
 
More and more patients and citizens contribute personal health data and human tissue to health research. This calls for measures aimed at privacy protection, personal data control, and active participant involvement in shaping research. In contributing to such goals, ethics parallel research can also help contribute to a responsible embedding of health research infrastructure in health care and society.

 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud biobank

Related news items


One year since the new business model for the Radboud Biobank was implemented

3 March 2026

The new business model was introduced last year, with departments paying half of the biomaterial processing costs, covering the storage costs, and applying a graduated rate for sample issuance.

go to page

Periodic invoicing biobank collections

3 March 2026

Since 2025, the Radboud Biobank periodically charges all biobank collections for the processing and storage costs incurred.

go to page

The purpose of a central biobank facility such as the Radboud Biobank

3 March 2026

As the central biobank facility of Radboudumc, the Radboud Biobank does more than simply store human biomaterials.

go to page

Radboud Biobank's 2025 annual report

3 March 2026

The Radboud Biobank's 2025 annual report is now available on request.

go to page

Aevai Health developed a virtual assistant

3 March 2026

Aevai Health has developed Alva - a virtual assistant to engage research participants, which can support participants with health literacy, understanding research protocols, and with using measurement devices.

go to page

Radboudumc Researchers Highlight Critical Gaps in Reporting Pre-Analytical Processes in Biobanked Biomaterials

21 October 2025

Radboudumc Researchers have identified significant shortcomings in pre-analytical sample processing reporting in clinical biomarker research, a factor crucial for study reliability and replicability.

go to page